SV

Sekharipuram Viswanathan Veeramani

Active Director Managing Director DIN 00907641
DIN 00907641 First appointment Mar 1979 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 1 historical roles
Total affiliations 3 Since Mar 1979
Shareholding value •••• Premium profile

About Sekharipuram Viswanathan Veeramani

Data last updated:

Sekharipuram Viswanathan Veeramani is a Managing Director at Fourrts (India) Laboratories Private Limited (since 1979) and Director at Tindivanam Pharma Park Association (since 2024). The companies operate in Pharma, Infrastructure and Utilities and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹779 Cr; the largest is Fourrts (India) Laboratories Private Limited at ₹778 Cr (FY 2025). Earlier, Sekharipuram Viswanathan Veeramani was a Director at Pharmaceuticals Export Promotion Council Of India (2021–2024).

DIN 00907641
Primary Designation Managing Director
Industry Pharma
First Appointment 31 Mar 1979
Oldest Company Age 47 yrs
Largest company Fourrts (India) Laboratories Private Limited · ₹778 Cr (FY 2025)
Combined revenue ₹779 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director31 Mar 19791979₹778 Cr (FY 2025)Active
Tindivanam Pharma Park Association U85300TN2023NPL158185
Director27 Dec 20242023₹61.2 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jan 20212004₹35.95 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Fourrts (India) Laboratories Private Limited
Tindivanam Pharma Park Association
Pharmaceuticals Export Promotion Council Of India
Premium access

Shareholding and investment profile for Sekharipuram Viswanathan Veeramani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekharipuram Viswanathan Veeramani

Sekharipuram Viswanathan Veeramani currently holds 2 directorships: Fourrts (India) Laboratories Private Limited (Managing Director, since 31 Mar 1979, revenue ₹778 Cr (FY 2025)); Tindivanam Pharma Park Association (Director, since 27 Dec 2024, revenue ₹61.2 Lakh (FY 2025)).

Sekharipuram Viswanathan Veeramani was first appointed on 31 Mar 1979 as Managing Director at Fourrts (India) Laboratories Private Limited. The most recent appointment on record is 27 Dec 2024 at Tindivanam Pharma Park Association.

The 2 current companies of Sekharipuram Viswanathan Veeramani that report revenue have a combined latest revenue of ₹779 Cr: Fourrts (India) Laboratories Private Limited ₹778 Cr (FY 2025); Tindivanam Pharma Park Association ₹61.2 Lakh (FY 2025).

Sekharipuram Viswanathan Veeramani held 1 earlier board appointment: Pharmaceuticals Export Promotion Council Of India (Director, 18 Jan 2021 to 23 Dec 2024).

The current boards of Sekharipuram Viswanathan Veeramani's companies include Gayatri Veeramani Jayaraman (Fourrts (India) Laboratories Private Limited), Mohan Lakshminarayan Iyer (Fourrts (India) Laboratories Private Limited), Nitia Mohan (Fourrts (India) Laboratories Private Limited), Rathinasamy Ashokkumar (Fourrts (India) Laboratories Private Limited), Sundar Jayaraman (Fourrts (India) Laboratories Private Limited), Veerramani Radha (Fourrts (India) Laboratories Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available